FR2798149A1 - USE OF LIPOAMINOACIDS IN THE MANUFACTURE OF PAPER PRODUCTS AND PAPER PRODUCTS COMPRISING THE SAME - Google Patents
USE OF LIPOAMINOACIDS IN THE MANUFACTURE OF PAPER PRODUCTS AND PAPER PRODUCTS COMPRISING THE SAME Download PDFInfo
- Publication number
- FR2798149A1 FR2798149A1 FR9911221A FR9911221A FR2798149A1 FR 2798149 A1 FR2798149 A1 FR 2798149A1 FR 9911221 A FR9911221 A FR 9911221A FR 9911221 A FR9911221 A FR 9911221A FR 2798149 A1 FR2798149 A1 FR 2798149A1
- Authority
- FR
- France
- Prior art keywords
- weight
- acid
- formula
- composition used
- approximately
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 6
- 239000000203 mixture Substances 0.000 claims abstract description 33
- 150000001875 compounds Chemical class 0.000 claims abstract description 26
- 150000003839 salts Chemical class 0.000 claims abstract description 12
- 150000001413 amino acids Chemical class 0.000 claims abstract description 11
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 8
- 229930195729 fatty acid Natural products 0.000 claims abstract description 8
- 239000000194 fatty acid Substances 0.000 claims abstract description 8
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 8
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 7
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 3
- 239000000835 fiber Substances 0.000 claims abstract 2
- 239000000284 extract Substances 0.000 claims description 22
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 14
- FSYKKLYZXJSNPZ-UHFFFAOYSA-N sarcosine Chemical compound C[NH2+]CC([O-])=O FSYKKLYZXJSNPZ-UHFFFAOYSA-N 0.000 claims description 13
- 239000007864 aqueous solution Substances 0.000 claims description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 10
- 239000002253 acid Substances 0.000 claims description 10
- 235000001014 amino acid Nutrition 0.000 claims description 10
- 229940024606 amino acid Drugs 0.000 claims description 10
- -1 octanoyl (capryloyl) Chemical group 0.000 claims description 10
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- 239000004471 Glycine Substances 0.000 claims description 7
- 108010077895 Sarcosine Proteins 0.000 claims description 6
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims description 6
- 235000011187 glycerol Nutrition 0.000 claims description 5
- 229940043230 sarcosine Drugs 0.000 claims description 5
- 235000013311 vegetables Nutrition 0.000 claims description 5
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 claims description 4
- 241000196324 Embryophyta Species 0.000 claims description 4
- XOAIXMQPJQVGRV-IBGZPJMESA-N N-Palmitoyl proline Chemical compound CCCCCCCCCCCCCCCC(=O)N1CCC[C@H]1C(O)=O XOAIXMQPJQVGRV-IBGZPJMESA-N 0.000 claims description 4
- 240000002853 Nelumbo nucifera Species 0.000 claims description 4
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 4
- 241000209490 Nymphaea Species 0.000 claims description 4
- 235000016791 Nymphaea odorata subsp odorata Nutrition 0.000 claims description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 claims description 4
- 125000000400 lauroyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 4
- 210000004400 mucous membrane Anatomy 0.000 claims description 4
- 229940098465 tincture Drugs 0.000 claims description 4
- LFJJOPDNPVFCNZ-UHFFFAOYSA-N 2-[hexadecanoyl(methyl)amino]acetic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N(C)CC(O)=O LFJJOPDNPVFCNZ-UHFFFAOYSA-N 0.000 claims description 3
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 claims description 3
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 3
- 239000004472 Lysine Substances 0.000 claims description 3
- KMAOMYOPEIRFLB-SFHVURJKSA-N N-Palmitoyl glutamic acid Chemical compound CCCCCCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O KMAOMYOPEIRFLB-SFHVURJKSA-N 0.000 claims description 3
- 235000021314 Palmitic acid Nutrition 0.000 claims description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 3
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 claims description 3
- 229960001983 magnesium aspartate Drugs 0.000 claims description 3
- 239000000463 material Substances 0.000 claims description 3
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims description 3
- 125000001312 palmitoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 229910052700 potassium Inorganic materials 0.000 claims description 3
- 239000011591 potassium Substances 0.000 claims description 3
- 229940068988 potassium aspartate Drugs 0.000 claims description 3
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims description 2
- AVBJHQDHVYGQLS-AWEZNQCLSA-N (2s)-2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)N[C@H](C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-AWEZNQCLSA-N 0.000 claims description 2
- UYTOHYBIBPDOKX-ZDUSSCGKSA-N (2s)-2-(dodecanoylamino)propanoic acid Chemical compound CCCCCCCCCCCC(=O)N[C@@H](C)C(O)=O UYTOHYBIBPDOKX-ZDUSSCGKSA-N 0.000 claims description 2
- VCRXMSMANOGRCM-UHFFFAOYSA-N 2-(dodecanoylamino)butanedioic acid Chemical compound CCCCCCCCCCCC(=O)NC(C(O)=O)CC(O)=O VCRXMSMANOGRCM-UHFFFAOYSA-N 0.000 claims description 2
- 239000004475 Arginine Substances 0.000 claims description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 claims description 2
- 244000267222 Brasenia schreberi Species 0.000 claims description 2
- 241000723347 Cinnamomum Species 0.000 claims description 2
- 244000223760 Cinnamomum zeylanicum Species 0.000 claims description 2
- 241000208680 Hamamelis mollis Species 0.000 claims description 2
- LCWXJXMHJVIJFK-UHFFFAOYSA-N Hydroxylysine Natural products NCC(O)CC(N)CC(O)=O LCWXJXMHJVIJFK-UHFFFAOYSA-N 0.000 claims description 2
- PMMYEEVYMWASQN-DMTCNVIQSA-N Hydroxyproline Chemical compound O[C@H]1CN[C@H](C(O)=O)C1 PMMYEEVYMWASQN-DMTCNVIQSA-N 0.000 claims description 2
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 claims description 2
- AHLPHDHHMVZTML-BYPYZUCNSA-N L-Ornithine Chemical compound NCCC[C@H](N)C(O)=O AHLPHDHHMVZTML-BYPYZUCNSA-N 0.000 claims description 2
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 claims description 2
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 claims description 2
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 claims description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 claims description 2
- LEVWYRKDKASIDU-IMJSIDKUSA-N L-cystine Chemical compound [O-]C(=O)[C@@H]([NH3+])CSSC[C@H]([NH3+])C([O-])=O LEVWYRKDKASIDU-IMJSIDKUSA-N 0.000 claims description 2
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 claims description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 claims description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 claims description 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 claims description 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims description 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 claims description 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 claims description 2
- 239000005639 Lauric acid Substances 0.000 claims description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 claims description 2
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 2
- 241001480177 Nymphaea alba Species 0.000 claims description 2
- 241000209477 Nymphaeaceae Species 0.000 claims description 2
- AHLPHDHHMVZTML-UHFFFAOYSA-N Orn-delta-NH2 Natural products NCCCC(N)C(O)=O AHLPHDHHMVZTML-UHFFFAOYSA-N 0.000 claims description 2
- UTJLXEIPEHZYQJ-UHFFFAOYSA-N Ornithine Natural products OC(=O)C(C)CCCN UTJLXEIPEHZYQJ-UHFFFAOYSA-N 0.000 claims description 2
- 241000124033 Salix Species 0.000 claims description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims description 2
- 244000269722 Thea sinensis Species 0.000 claims description 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 claims description 2
- 239000004473 Threonine Substances 0.000 claims description 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 claims description 2
- 235000004279 alanine Nutrition 0.000 claims description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 claims description 2
- 229960001230 asparagine Drugs 0.000 claims description 2
- 235000009582 asparagine Nutrition 0.000 claims description 2
- 229960005261 aspartic acid Drugs 0.000 claims description 2
- 235000017803 cinnamon Nutrition 0.000 claims description 2
- 235000020230 cinnamon extract Nutrition 0.000 claims description 2
- 235000019864 coconut oil Nutrition 0.000 claims description 2
- 239000003240 coconut oil Substances 0.000 claims description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 claims description 2
- 235000018417 cysteine Nutrition 0.000 claims description 2
- 229960003067 cystine Drugs 0.000 claims description 2
- YSMODUONRAFBET-UHFFFAOYSA-N delta-DL-hydroxylysine Natural products NCC(O)CCC(N)C(O)=O YSMODUONRAFBET-UHFFFAOYSA-N 0.000 claims description 2
- PMMYEEVYMWASQN-UHFFFAOYSA-N dl-hydroxyproline Natural products OC1C[NH2+]C(C([O-])=O)C1 PMMYEEVYMWASQN-UHFFFAOYSA-N 0.000 claims description 2
- YSMODUONRAFBET-UHNVWZDZSA-N erythro-5-hydroxy-L-lysine Chemical compound NC[C@H](O)CC[C@H](N)C(O)=O YSMODUONRAFBET-UHNVWZDZSA-N 0.000 claims description 2
- 239000012634 fragment Substances 0.000 claims description 2
- 125000000268 heptanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 claims description 2
- QJHBJHUKURJDLG-UHFFFAOYSA-N hydroxy-L-lysine Natural products NCCCCC(NO)C(O)=O QJHBJHUKURJDLG-UHFFFAOYSA-N 0.000 claims description 2
- 229960002591 hydroxyproline Drugs 0.000 claims description 2
- 229960000310 isoleucine Drugs 0.000 claims description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 claims description 2
- 229930182817 methionine Natural products 0.000 claims description 2
- 125000001419 myristoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 2
- 229960003104 ornithine Drugs 0.000 claims description 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims description 2
- 235000018553 tannin Nutrition 0.000 claims description 2
- 229920001864 tannin Polymers 0.000 claims description 2
- 239000001648 tannin Substances 0.000 claims description 2
- FGMPLJWBKKVCDB-UHFFFAOYSA-N trans-L-hydroxy-proline Natural products ON1CCCC1C(O)=O FGMPLJWBKKVCDB-UHFFFAOYSA-N 0.000 claims description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims description 2
- 239000004474 valine Substances 0.000 claims description 2
- 229940118846 witch hazel Drugs 0.000 claims description 2
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 claims 2
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 claims 1
- JWGGSJFIGIGFSQ-UHFFFAOYSA-N N-dodecanoylglycine Chemical compound CCCCCCCCCCCC(=O)NCC(O)=O JWGGSJFIGIGFSQ-UHFFFAOYSA-N 0.000 claims 1
- SAVLIIGUQOSOEP-UHFFFAOYSA-N N-octanoylglycine Chemical compound CCCCCCCC(=O)NCC(O)=O SAVLIIGUQOSOEP-UHFFFAOYSA-N 0.000 claims 1
- 241000209485 Nuphar Species 0.000 claims 1
- 125000002714 alpha-linolenoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000003104 hexanoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- RXMQCXCANMAVIO-CEOVSRFSSA-L magnesium;(2s)-2-amino-4-hydroxy-4-oxobutanoate Chemical compound [H+].[H+].[Mg+2].[O-]C(=O)[C@@H](N)CC([O-])=O.[O-]C(=O)[C@@H](N)CC([O-])=O RXMQCXCANMAVIO-CEOVSRFSSA-L 0.000 claims 1
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims 1
- 125000001117 oleyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])/C([H])=C([H])\C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 125000003696 stearoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229910052749 magnesium Inorganic materials 0.000 description 4
- 239000011777 magnesium Substances 0.000 description 4
- 235000018102 proteins Nutrition 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 102000004169 proteins and genes Human genes 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 239000000470 constituent Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 239000003981 vehicle Substances 0.000 description 3
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical class [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 2
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 2
- 125000001124 arachidoyl group Chemical group O=C([*])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 2
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- YKZPPPNXRZHVGX-PXYKVGKMSA-L dipotassium;(2s)-2-aminobutanedioate;hydron;hydrate Chemical class [H+].[H+].O.[K+].[K+].[O-]C(=O)[C@@H](N)CC([O-])=O.[O-]C(=O)[C@@H](N)CC([O-])=O YKZPPPNXRZHVGX-PXYKVGKMSA-L 0.000 description 2
- 229940091250 magnesium supplement Drugs 0.000 description 2
- 125000002801 octanoyl group Chemical group C(CCCCCCC)(=O)* 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 229960000306 zinc gluconate Drugs 0.000 description 2
- 235000011478 zinc gluconate Nutrition 0.000 description 2
- 239000011670 zinc gluconate Substances 0.000 description 2
- 229940043375 1,5-pentanediol Drugs 0.000 description 1
- 235000009434 Actinidia chinensis Nutrition 0.000 description 1
- 244000298697 Actinidia deliciosa Species 0.000 description 1
- 235000009436 Actinidia deliciosa Nutrition 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 108010076119 Caseins Proteins 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical class [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 108010028690 Fish Proteins Proteins 0.000 description 1
- 108010002537 Fruit Proteins Proteins 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 235000003222 Helianthus annuus Nutrition 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241000219745 Lupinus Species 0.000 description 1
- 235000011430 Malus pumila Nutrition 0.000 description 1
- 244000070406 Malus silvestris Species 0.000 description 1
- 235000015103 Malus silvestris Nutrition 0.000 description 1
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical class [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- SAVLIIGUQOSOEP-UHFFFAOYSA-M N-octanoylglycinate Chemical compound CCCCCCCC(=O)NCC([O-])=O SAVLIIGUQOSOEP-UHFFFAOYSA-M 0.000 description 1
- 244000108404 Nuphar japonicum Species 0.000 description 1
- 229920001131 Pulp (paper) Polymers 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 239000004902 Softening Agent Substances 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 235000010749 Vicia faba Nutrition 0.000 description 1
- 240000006677 Vicia faba Species 0.000 description 1
- 235000002098 Vicia faba var. major Nutrition 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical class [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 229910052782 aluminium Chemical class 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical class [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 125000001204 arachidyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940009098 aspartate Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 238000004061 bleaching Methods 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- ZMIGMASIKSOYAM-UHFFFAOYSA-N cerium Chemical class [Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce] ZMIGMASIKSOYAM-UHFFFAOYSA-N 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 125000003074 decanoyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C(*)=O 0.000 description 1
- 125000002704 decyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 159000000011 group IA salts Chemical class 0.000 description 1
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000007794 irritation Effects 0.000 description 1
- 229910052746 lanthanum Inorganic materials 0.000 description 1
- FZLIPJUXYLNCLC-UHFFFAOYSA-N lanthanum atom Chemical class [La] FZLIPJUXYLNCLC-UHFFFAOYSA-N 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- 229910052748 manganese Chemical class 0.000 description 1
- 239000011572 manganese Chemical class 0.000 description 1
- 125000002960 margaryl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 125000001421 myristyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- HFWWEMPLBCKNNM-UHFFFAOYSA-N n-[bis(hydroxyamino)methyl]hydroxylamine Chemical compound ONC(NO)NO HFWWEMPLBCKNNM-UHFFFAOYSA-N 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 125000001196 nonadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000001400 nonyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000002891 organic anions Chemical class 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002958 pentadecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 230000007065 protein hydrolysis Effects 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 159000000008 strontium salts Chemical class 0.000 description 1
- 125000002889 tridecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 125000002948 undecyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- D—TEXTILES; PAPER
- D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
- D21H—PULP COMPOSITIONS; PREPARATION THEREOF NOT COVERED BY SUBCLASSES D21C OR D21D; IMPREGNATING OR COATING OF PAPER; TREATMENT OF FINISHED PAPER NOT COVERED BY CLASS B31 OR SUBCLASS D21G; PAPER NOT OTHERWISE PROVIDED FOR
- D21H17/00—Non-fibrous material added to the pulp, characterised by its constitution; Paper-impregnating material characterised by its constitution
- D21H17/03—Non-macromolecular organic compounds
- D21H17/05—Non-macromolecular organic compounds containing elements other than carbon and hydrogen only
- D21H17/07—Nitrogen-containing compounds
Landscapes
- Cosmetics (AREA)
- Detergent Compositions (AREA)
Abstract
L'invention a pour objet l'utilisation d'une composition comprenant une quantité efficace d'au moins un composé de formule (I) : (CF DESSIN DANS BOPI) ou ses sels topiquement acceptables, dans laquelle R représente la chaîne caractérisante d'un acide gras, saturé ou insaturé, linéaire ou ramifié, comportant de 3 à 30 atomes de carbone, R1 ou (CF DESSIN DANS BOPI) représente la chaîne ou le radical cyclique caractérisant d'un aminoacide et m est compris entre 1 et 5, pour la fabrication de produits papetiers. Produit papetier à base de fibres papetières comportant ledit composé.The subject of the invention is the use of a composition comprising an effective amount of at least one compound of formula (I): (CF DRAWING IN BOPI) or its topically acceptable salts, in which R represents the characterizing chain of a fatty acid, saturated or unsaturated, linear or branched, comprising from 3 to 30 carbon atoms, R1 or (CF DRAWING IN BOPI) represents the chain or the cyclic radical characterizing an amino acid and m is between 1 and 5, for the manufacture of paper products. Paper product based on paper fibers comprising the said compound.
Description
<Desc/Clms Page number 1> <Desc / Clms Page number 1>
L'invention a pour objet, une nouvelle utilisation des (oligo)aminoacides Nacylés. The subject of the invention is a new use of Nacylated (oligo) amino acids.
Les (oligo)aminoacides N-acylés, appelés aussi, lipoaminoacides lorsque le radical acyle est dérivé d'un acide gras, comme par exemple ceux décrits dans les demandes internationales de brevet publiées sous les numéros W092/20647, W092/21318, W094/26694 et W094/27561, sont couramment utilisés dans la préparation de produits cosmétiques. N-acylated (oligo) amino acids, also called lipoamino acids when the acyl radical is derived from a fatty acid, such as for example those described in the international patent applications published under the numbers W092 / 20647, W092 / 21318, W094 / 26694 and W094 / 27561 are commonly used in the preparation of cosmetic products.
La cellulose, quelle que soit sa forme, lorsqu'elle est traitée par des agents alcalins, des produits de blanchiment ou de lavage, acquiert un toucher sec, dur et peu agréable. C'est pourquoi, depuis de nombreuses années, on utilise des produits d'adoucissage ou d'assouplissage dans l'industrie papetière. On distingue de façon générale deux catégories de composés d'adoucissage ; il y a ceux qui sont incorporés directement dans la pâte de cellulose à papier et ceux qui sont appliqués en surface d'un produit cellulosique telle qu'une feuille de papier, que ce soit avant séchage ou après séchage dudit produit. Cellulose, whatever its form, when treated with alkaline agents, bleaching or washing products, acquires a dry, hard and unpleasant feel. This is why, for many years, softening or softening products have been used in the paper industry. There are generally two categories of softening compounds; there are those which are incorporated directly into the pulp of paper pulp and those which are applied on the surface of a cellulosic product such as a sheet of paper, either before drying or after drying of said product.
Un grand nombre de dérivés d'ammonium quaternaire ont été utilisés comme agent d'adoucissage ; ils contiennent une ou plusieurs chaînes grasses, dont le nombre d'atomes de carbone est compris entre 8 et 32 atomes de carbone. A large number of quaternary ammonium derivatives have been used as a softening agent; they contain one or more fatty chains, the number of carbon atoms of which is between 8 and 32 carbon atoms.
La demanderesse a cherché à mettre au point des composés que l'on incorpore à la pâte de cellulose ou que l'on applique sur le produit cellulosique final, qui procurent à ce produit un toucher doux et glissant, qui ne provoquent pas d'irritations lors du frottement dudit produit sur la peau ou les muqueuses, tout en ne dégradant pas sa résistance initiale au déchirement ni sa capacité absorption des liquides. The Applicant has sought to develop compounds which are incorporated into the cellulose pulp or which are applied to the final cellulosic product, which give this product a soft and slippery feel, which does not cause irritation. when rubbing said product on the skin or mucous membranes, while not degrading its initial resistance to tearing or its ability to absorb liquids.
C'est pourquoi l'invention a pour objet l'utilisation d'une composition comprenant une quantité efficace d'au moins un composé de formule (I) :
<Desc/Clms Page number 2><Desc / Clms Page number 2>
ou ses sels topiquement acceptables, dans laquelle R représente la chaîne caractérisante d'un acide gras, saturé ou insaturé, linéaire ou ramifié, comportant de 3 à 30 atomes de carbone, R1 ou
représente la chaîne ou le radical cyclique caractérisant d'un aminoacide et m est compris entre 1 et 5, pour la fabrication de produits papetiers. or its topically acceptable salts, in which R represents the characterizing chain of a fatty acid, saturated or unsaturated, linear or branched, containing from 3 to 30 carbon atoms, R1 or
represents the chain or the cyclic radical characterizing an amino acid and m is between 1 and 5, for the manufacture of paper products.
Par produits papetiers, on désigne tout particulièrement dans le cadre de la présente invention, les papiers ou supports non tissées à usage sanitaire ou domestique dont l'utilisation implique un contact direct avec la peau ou les muqueuses. Il s'agit par exemple, de mouchoirs en papier, d'essuie-mains en papier, de papier toilette, d'essuie-tout, de lingettes à démaquiller, en papier ou sur support non tissé. By paper products is meant very particularly in the context of the present invention, non-woven papers or supports for sanitary or domestic use, the use of which involves direct contact with the skin or the mucous membranes. These are, for example, handkerchiefs, paper towels, toilet paper, paper towels, make-up removal wipes, paper or non-woven media.
Par sel topiquement acceptable, on entend tout sel de l'acide de formule (1) biologiquement acceptable pour la peau et/ou les muqueuses, c'est à dire tout sel pouvant notamment régler le pH de la composition à une valeur comprise entre 3 et 8 et de préférence environ égale à 5, c'est à dire à un pH voisin de celui de la peau. Il peut s'agir notamment de sels alcalins tels que les sels de sodium, de potassium ou de lithium, de sels alcalino-terreux tels que les sels de calcium, de magnésium ou de strontium ; il peut aussi s'agir de sels métalliques tels que les sels divalents de zinc, de cuivre ou de manganèse ou encore les sels trivalents de fer, de lanthane, de cérium ou d'aluminium ou enfin de sels d'amines. The term “topically acceptable salt” means any salt of the acid of formula (1) which is biologically acceptable for the skin and / or the mucous membranes, ie any salt which can in particular adjust the pH of the composition to a value between 3 and 8 and preferably approximately equal to 5, that is to say at a pH close to that of the skin. They may especially be alkaline salts such as the sodium, potassium or lithium salts, alkaline earth salts such as the calcium, magnesium or strontium salts; it can also be metallic salts such as divalent salts of zinc, copper or manganese or also trivalent salts of iron, lanthanum, cerium or aluminum or finally amine salts.
Par au moins un composé de formule (1), on indique que la composition mise en #uvre dans l'utilisation selon l'invention peut contenir un ou plusieurs de ces composés. By at least one compound of formula (1), it is indicated that the composition used in the use according to the invention may contain one or more of these compounds.
Le ou les composés de formule (1), peuvent être sous forme d'acide libre ou sous forme partiellement ou totalement salifiée. The compound (s) of formula (1) can be in the form of free acid or in partially or fully salified form.
L'expression "chaîne caractérisante" utilisée dans le cadre de la présente demande de brevet, désigne la chaîne principale non fonctionnelle de l'acide gras ou de l'acide aminé considéré. The expression "characterizing chain" used in the context of the present patent application denotes the non-functional main chain of the fatty acid or of the amino acid considered.
<Desc/Clms Page number 3> <Desc / Clms Page number 3>
Ainsi, pour un acide gras répondant à la formule générale R-COOH, la chaîne caractérisante sera la chaîne linéaire ou ramifiée, représentée par R. Le radical R représente notamment un radical comportant de 5 à 22 atomes de carbone choisi parmi les radicaux pentyle, hexyle, heptyle, octyle, nonyle, décyle, undécyle, dodécyle, tridécyle, tétradécyle, pentadécyle, hexadécyle, heptadécyle, octadécyle, nonadécyle, eicosyle, uneicosyle, docosyle, heptadécènyle, eicosènyle, uneicosènyle, docosènyle ou heptadécadiènyle ou décènyle. L'invention a plus particulièrement pour objet l'utilisation, telle que définie précédemment, dans laquelle, dans la formule (1), le fragment R-CO comporte de 7 à 22 atomes de carbone et représente notamment l'un des radicaux hexanoyle, heptanoyle, octanoyle (capryloyle), décanoyle (caproyle), undécylènoyle, dodécanoyle (lauroyle), tétradécanoyle (myristyle), hexadécanoyle (palmitoyle), octadécanoyle (stéaryle), eicosanoyle (arachidoyle), docosanoyle (behènoyle), octodécènoyle (oléyle), éicosènoyle (gadoloyle), docosènoyle (érucyle), octadécadiènoyle (linolènoyle). Thus, for a fatty acid corresponding to the general formula R-COOH, the characterizing chain will be the linear or branched chain, represented by R. The radical R represents in particular a radical containing from 5 to 22 carbon atoms chosen from pentyl radicals, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, nonadecyl, eicosyl, unicosyl, docosyl, heptadecenyl, eicosenyl, unicosenyl or docosenyl or docosenyl A more particular subject of the invention is the use, as defined above, in which, in formula (1), the R-CO fragment contains from 7 to 22 carbon atoms and represents in particular one of the hexanoyl radicals, heptanoyl, octanoyl (capryloyl), decanoyl (caproyl), undecylenoyl, dodecanoyl (lauroyl), tetradecanoyl (myristyle), hexadecanoyl (palmitoyle), octadecanoyle (stearyl), eosanosoyle (arachidoyl), arachidoyle (arachidoyle), arachidoyle (arachidoyl) (gadoloyl), docosènoyl (erucyle), octadécadiènoyle (linolènoyl).
Un aminoacide représenté par la formule générale
H2N-CHR1-COOH, sera caractérisé par la définition de Ri . An amino acid represented by the general formula
H2N-CHR1-COOH, will be characterized by the definition of Ri.
Un acide aminé représenté par la formule :
sera caractérisé par la définition du radical cyclique :
Dans le cadre de la présente invention, la chaîne ou le radical cyclique caractérisant l'aminoacide sont choisis parmi la glycine, l'alanine, la sérine, l'acide aspartique, l'acide glutamique, la valine, la thréonine, l'arginine, la lysine, la An amino acid represented by the formula:
will be characterized by the definition of the cyclic radical:
In the context of the present invention, the chain or the cyclic radical characterizing the amino acid are chosen from glycine, alanine, serine, aspartic acid, glutamic acid, valine, threonine, arginine , lysine,
<Desc/Clms Page number 4><Desc / Clms Page number 4>
proline, la leucine, la phénylalanine, l'isoleucine, l'histidine, la tyrosine, le tryptophane, l'asparagine, la cystéine, la cystine, la méthionine, l'hydroxyproline, l'hydroxylysine et l'ornithine. proline, leucine, phenylalanine, isoleucine, histidine, tyrosine, tryptophan, asparagine, cysteine, cystine, methionine, hydroxyproline, hydroxylysine and ornithine.
Selon un premier aspect particulier de la présente invention celle-ci a pour objet une utilisation telle que définie précédemment, dans laquelle le ou les composés de formule (I) contenus dans la composition mise en #uvre, sont associés avec au moins un extrait et/ou teinture de matières végétale riche en tannin choisi parmi les extraits de thé de cannelle, de saule ou d'hamamélis. According to a first particular aspect of the present invention, its subject is a use as defined above, in which the compound or compounds of formula (I) contained in the composition used, are associated with at least one extract and / or tincture of vegetable matter rich in tannin chosen from cinnamon, willow or witch hazel tea extracts.
Selon un deuxième aspect particulier de la présente invention celle-ci a pour objet l'utilisation telle que définie précédemment, dans laquelle le ou les composés de formule (I) contenus dans la composition mise en oeuvre, sont associés avec au moins un extrait de matières végétales choisi parmi les extraits de plantes de la famille des nymphéacées, et tout particulièrement avec au moins un extrait de fleur de nénuphar tel que "Nuphar japonicum", de lotus tel que "Nelumbo nucifera" ou de "Brasenia purpurea". According to a second particular aspect of the present invention, its subject is the use as defined above, in which the compound or compounds of formula (I) contained in the composition used, are associated with at least one extract of plant materials chosen from plant extracts of the water lily family, and in particular with at least one water lily flower extract such as "Nuphar japonicum", lotus such as "Nelumbo nucifera" or "Brasenia purpurea".
Dans les définitions précédentes, les mots extrait et teinture sont utilisés dans leurs sens respectifs, tels qu'ils sont établis dans l'édition de 1997 de la Pharmacopée européenne ; les extraits (extracts) sont des préparations concentrées, liquides, solides ou de consistance intermédiaire, généralement obtenues à partir de matières premières végétales ou animales séchées. Les teintures (tincturae) sont des préparations généralement obtenues à partir de matières premières végétales ou animales séchées. In the previous definitions, the words extract and tincture are used in their respective meanings, as established in the 1997 edition of the European Pharmacopoeia; extracts (extracts) are concentrated preparations, liquids, solids or of intermediate consistency, generally obtained from dried vegetable or animal raw materials. Tinctures (tincturae) are preparations generally obtained from dried vegetable or animal raw materials.
Outre les principes actifs, la composition mise en #uvre dans l'invention, comprend des véhicules minéraux ou organiques couramment utilisés tel que par exemple l'eau, les polyols comme le propylèneglycol, le dipropylèneglycol, le butylèneglycol, le pentylèneglycol, l'hexylèneglycol, le caprylglycol ou la glycérine. In addition to the active principles, the composition used in the invention comprises inorganic or organic vehicles commonly used such as, for example, water, polyols such as propylene glycol, dipropylene glycol, butylene glycol, pentylene glycol, hexylene glycol. , caprylglycol or glycerin.
La composition mise en #uvre dans la présente invention, peut aussi comprendre une ou plusieurs bases de neutralisation, comme le tris (trishydroxyaminométhane), du triéthanolamine de la lysine ou du méthyl glycine (sarcosine). The composition used in the present invention may also comprise one or more neutralizing bases, such as tris (trishydroxyaminomethane), triethanolamine, lysine or methyl glycine (sarcosine).
<Desc/Clms Page number 5> <Desc / Clms Page number 5>
Elle peut aussi comprendre d'autres composés tels que par exemple des sels métalliques d'anions organiques tels que par exemple, l'aspartate de magnésium et de potassium et/ou le gluconate de zinc. It can also include other compounds such as for example metal salts of organic anions such as for example, magnesium and potassium aspartate and / or zinc gluconate.
Les composés de formule (I) sont généralement obtenus par acylation de composés de formule (I')
ou de leurs sels, eux-mêmes obtenus par hydrolyse totale ou partielle de protéines de toutes origines Une telle méthode est connue de l'homme du métier Ces protéines peuvent être d'origine animale, telles que, par exemple, le collagène, l'élastine, la protéine de chair de poissons, la gélatine de poissons, la kératine ou la caséine, d'origine végétale, comme les protéines de céréales, de fleurs ou de fruits, telles que par exemple, les protéines issues du soja, du tournesol, de l'avoine, du blé, du maïs, de l'orge, de la pomme de terre, du lupin, de la féverole, de l'amande douce, du kiwi, de la mangue ou de la pomme ; il peut s'agir aussi de protéines obtenues à partir de chorelles (algues unicellulaires), d'algues roses, de levures ou de la soie. Quand m est supérieur à 1, R1 représente plusieurs des chaînes caractérisantes des acides aminés, selon la protéine hydrolysée et le degré d'hydrolyse. The compounds of formula (I) are generally obtained by acylation of compounds of formula (I ')
or their salts, themselves obtained by total or partial hydrolysis of proteins of all origins. Such a method is known to those skilled in the art. These proteins can be of animal origin, such as, for example, collagen, elastin, fish flesh protein, fish gelatin, keratin or casein, of plant origin, such as cereal, flower or fruit proteins, such as for example proteins from soybeans, sunflower , oats, wheat, corn, barley, potato, lupine, faba bean, sweet almond, kiwi, mango or apple; it can also be proteins obtained from chorelles (unicellular algae), pink algae, yeasts or silk. When m is greater than 1, R1 represents several of the characterizing chains of amino acids, depending on the hydrolyzed protein and the degree of hydrolysis.
Dans une variante particulière de l'utilisation objet de la présente invention, dans la formule (1) représentant le ou les composés de formule (1) contenus dans la composition mise en #uvre, m est inférieur à 2 et est de préférence égal à 1. In a particular variant of the use which is the subject of the present invention, in the formula (1) representing the compound or compounds of formula (1) contained in the composition used, m is less than 2 and is preferably equal to 1.
La composition mise en #uvre dans l'utilisation selon l'invention, comprend environ de 15% à 60% et, plus particulièrement environ de 20% à 40% en poids, d'au moins un composé de formule (1) tel que définie précédemment. Lorsqu'elle comprend un ou plusieurs extraits et/ ou teintures de matière végétale, elle en contient environ de 0,1% à 10% et plus particulièrement de 0,5% à 5% en poids. The composition used in the use according to the invention comprises approximately 15% to 60% and, more particularly approximately 20% to 40% by weight, of at least one compound of formula (1) such as previously defined. When it comprises one or more extracts and / or tinctures of vegetable matter, it contains about 0.1% to 10% and more particularly from 0.5% to 5% by weight.
Selon la Pharmacopée européenne, les extraits peuvent être sous forme d'extraits fluides, d'extraits mous ou fermes ou d'extraits secs. Dans la définition précédente, les pourcentages pondéraux en constituants de l'extrait ou de la teinture correspondent aux pourcentages pondéraux en résidu sec, ledit résidu According to the European Pharmacopoeia, the extracts can be in the form of fluid extracts, soft or firm extracts or dry extracts. In the above definition, the weight percentages of constituents of the extract or of the dye correspond to the weight percentages of dry residue, said residue
<Desc/Clms Page number 6><Desc / Clms Page number 6>
sec étant obtenu par évaporation du solvant et dessiccation dudit extrait ou de ladite teinture à des conditions opératoires auxquelles l'altération des constituants est minime. dry being obtained by evaporation of the solvent and drying of said extract or of said dye under operating conditions in which the alteration of the constituents is minimal.
Lorsque la composition mise en #uvre comprend d'autres composés, tels que par exemple l'aspartate de magnésium et de potassium et/ou le gluconate de zinc, elle en contient généralement de 0,1% à 10% et plus particulièrement de 0,5% à 5% en poids. When the composition used comprises other compounds, such as for example magnesium and potassium aspartate and / or zinc gluconate, it generally contains from 0.1% to 10% and more particularly from 0 , 5% to 5% by weight.
La composition, objet de la présente invention est préparée selon des méthodes connues de l'homme du métier, en général, par simple agitation du mélange de ses constituants dans le véhicule liquide adéquat. Si nécessaire ou si désiré, ledit extrait et/ou la dite teinture sont préalablement dilués avant mélange. The composition which is the subject of the present invention is prepared according to methods known to those skilled in the art, in general, by simple stirring of the mixture of its constituents in the appropriate liquid vehicle. If necessary or if desired, said extract and / or said tincture are previously diluted before mixing.
L'invention a plus particulièrement pour objet, l'utilisation telle que définie précédemment, dans laquelle la composition mise en #uvre est une solution aqueuse comprenant environ de 6% à 10% en poids d'acide N-lauroyl glutamique, de 3% à 8% en poids d'acide N-lauroyl aspartique, de 2% à 5% en poids de Nlauroyl glycine, de 2 à 4% en poids de N-lauroyl alanine, de 0,5 à 2% en poids d'aspartate mixte de potassium et de magnésium, de 20% à 25% en poids de propylène glycol et de 4% à 10% en poids de sarcosine, de 3% à 6% d'acide laurique. A more particular subject of the invention is the use as defined above, in which the composition used is an aqueous solution comprising approximately from 6% to 10% by weight of N-lauroyl glutamic acid, of 3% to 8% by weight of N-lauroyl aspartic acid, from 2% to 5% by weight of Nlauroyl glycine, from 2 to 4% by weight of N-lauroyl alanine, from 0.5 to 2% by weight of aspartate mixed potassium and magnesium, from 20% to 25% by weight of propylene glycol and from 4% to 10% by weight of sarcosine, from 3% to 6% of lauric acid.
L'invention a plus particulièrement pour objet, l'utilisation telle que définie précédemment, dans laquelle la composition mise en #uvre est une solution aqueuse comprenant environ de 20% à 30% en poids d'acide N-octanoyl glycine, de 3% en poids d'extrait de cannelle (Cinnamomum zelanicum) de 5% à 15% en poids de glycérine, de 5% à 15% en poids de butylène glycol et de 4% à 10% en poids de sarcosine. A more particular subject of the invention is the use as defined above, in which the composition used is an aqueous solution comprising approximately from 20% to 30% by weight of N-octanoyl glycine acid, of 3% by weight of cinnamon extract (Cinnamomum zelanicum) from 5% to 15% by weight of glycerin, from 5% to 15% by weight of butylene glycol and from 4% to 10% by weight of sarcosine.
L'invention a plus particulièrement pour objet, l'utilisation telle que définie précédemment, dans laquelle la composition mise en #uvre est une solution aqueuse comprenant environ de 20% à 30% en poids d'acide N-undécènoyl glycine et de 5% à 15% en poids de glycérine. A more particular subject of the invention is the use as defined above, in which the composition used is an aqueous solution comprising approximately from 20% to 30% by weight of N-undecenoyl glycine acid and 5% 15% by weight of glycerin.
L'invention a plus particulièrement pour objet, l'utilisation telle que définie précédemment, dans laquelle la composition mise en #uvre est une solution A more particular subject of the invention is the use as defined above, in which the composition used is a solution
<Desc/Clms Page number 7><Desc / Clms Page number 7>
aqueuse comprenant environ de 25% à 35% en poids de N-palmitoyl proline et 0,1% en poids d'extrait de fleur de nénuphar (Nymphaea Alba). aqueous comprising approximately from 25% to 35% by weight of N-palmitoyl proline and 0.1% by weight of water lily extract (Nymphaea Alba).
L'invention a plus particulièrement pour objet, l'utilisation telle que définie précédemment, dans laquelle la composition mise en #uvre est une solution aqueuse comprenant environ de 30% à 50% en poids de N-palmitoyl proline, de 10% à 15% en poids d'acide N-palmitoyl glutamique, de 10% à 15% en poids de N-palmitoyl sarcosine et de 25% à 35% en poids d'acide palmitique. A more particular subject of the invention is the use as defined above, in which the composition used is an aqueous solution comprising approximately from 30% to 50% by weight of N-palmitoyl proline, from 10% to 15 % by weight of N-palmitoyl glutamic acid, from 10% to 15% by weight of N-palmitoyl sarcosine and from 25% to 35% by weight of palmitic acid.
L'invention a plus particulièrement pour objet, l'utilisation telle que définie précédemment, dans laquelle la composition mise en #uvre est une solution aqueuse comprenant environ de 30% à 70% en poids de N-cocoyl glycine, de 0% à 25% en poids d'acide N-cocoyl sarcosine, et 5% à 20% en poids du mélange d'acides gras issus de l'huile de coprah. A more particular subject of the invention is the use as defined above, in which the composition used is an aqueous solution comprising approximately from 30% to 70% by weight of N-cocoyl glycine, from 0% to 25 % by weight of N-cocoyl sarcosine acid, and 5% to 20% by weight of the mixture of fatty acids obtained from coconut oil.
La composition est mise en #uvre selon des méthodes connues de l'homme du métier. Elle peut être appliquée ou imprégnée après dilution entre environ 2% et 5% en poids dans un véhicule liquide appropriée, par exemple de l'eau ou un polyol, sur le produit papetier à raison d'environ 0,3 grammes à 15 grammes de solution diluée pour 100 grammes de produit papetier. Le produit papetier ainsi obtenu, contient entre environ 0,0005% et 0,5% en poids de composé de formule (1) telle que défini précédemment. The composition is used according to methods known to those skilled in the art. It can be applied or impregnated after dilution between approximately 2% and 5% by weight in a suitable liquid vehicle, for example water or a polyol, on the paper product in an amount of approximately 0.3 grams to 15 grams of diluted solution for 100 grams of paper product. The papermaking product thus obtained contains between about 0.0005% and 0.5% by weight of compound of formula (1) as defined above.
L'exemple suivant illustre l'invention sans toutefois la limiter. The following example illustrates the invention without however limiting it.
A) On a préparé une composition comprenant environ 45% en poids de Npalmitoyl proline, de 10% à 15% en poids d'acide N-palmitoyl glutamique, de 10% à 15% en poids de N-palmitoyl sarcosine et 30% en poids d'acide palmitique. A) A composition was prepared comprising approximately 45% by weight of Npalmitoyl proline, from 10% to 15% by weight of N-palmitoyl glutamic acid, from 10% to 15% by weight of N-palmitoyl sarcosine and 30% by weight. weight of palmitic acid.
B) On dilue cette composition à 3% dans une solution aqueuse à 20% de butylèneglycol. B) This composition is diluted to 3% in a 20% aqueous solution of butylene glycol.
C) on pulvérise finement cette solution à raison de 10 grammes de solution pour 100g de papier, sur les deux faces de deux cents mouchoirs en papier disponibles dans le commerce, préalablement dépliés. On laisse les laisse sécher 24 heures, sous air sec à 40 C, puis on replie les mouchoirs et une fois les deux cents mouchoirs ainsi préparés, on réalise un test sensoriel avec un panel de 20 personnes. C) this solution is finely sprayed at the rate of 10 grams of solution per 100g of paper, on the two sides of two hundred commercially available handkerchiefs, previously unfolded. They are left to dry for 24 hours, under dry air at 40 ° C., then the tissues are folded back and once the two hundred tissues thus prepared, a sensory test is carried out with a panel of 20 people.
<Desc/Clms Page number 8> <Desc / Clms Page number 8>
Les appréciations du panel ont porté sur la sensation de douceur au toucher
On a distribué à chacune des 20 personnes du panel, vingt mouchoirs en papier parmi lesquels seulement 10 avaient été traités comme décrit ci-dessus. On leur a ensuite demandé de séparer les mouchoirs en cinq catégories, selon qu'ils leur paraissaient : très doux au toucher (++++) doux au toucher (+++) plutôt rêches au toucher (---) très rêches au toucher(---) inclassables (0) les résultats sont les suivants : 14 personnes sur les 20 du panel, ont classé l'ensemble des mouchoirs traités dans les catégories (++++) ou (+++) et l'ensemble des mouchoirs non traités dans les catégories (0), (---) ou (----). The panel's assessments focused on the feeling of softness to the touch
Twenty facial tissues were distributed to each of the 20 people on the panel, of which only 10 had been treated as described above. They were then asked to separate the handkerchiefs into five categories, according to what they thought: very soft to the touch (++++) soft to the touch (+++) rather rough to the touch (---) very rough to the touch (---) unclassifiable (0) the results are as follows: 14 people out of the 20 on the panel, classified all of the handkerchiefs treated in the categories (++++) or (+++) and the all handkerchiefs not treated in categories (0), (---) or (----).
Claims (15)
Priority Applications (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9911221A FR2798149B1 (en) | 1999-09-08 | 1999-09-08 | USE OF LIPOAMINOACIDS IN THE MANUFACTURE OF PAPER PRODUCTS AND PAPER PRODUCTS COMPRISING THE SAME |
| EP00402303A EP1083261A1 (en) | 1999-09-08 | 2000-08-17 | Use of lipoaminoacids in making of paper products, and paper products containing them |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9911221A FR2798149B1 (en) | 1999-09-08 | 1999-09-08 | USE OF LIPOAMINOACIDS IN THE MANUFACTURE OF PAPER PRODUCTS AND PAPER PRODUCTS COMPRISING THE SAME |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2798149A1 true FR2798149A1 (en) | 2001-03-09 |
| FR2798149B1 FR2798149B1 (en) | 2001-11-09 |
Family
ID=9549631
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR9911221A Expired - Fee Related FR2798149B1 (en) | 1999-09-08 | 1999-09-08 | USE OF LIPOAMINOACIDS IN THE MANUFACTURE OF PAPER PRODUCTS AND PAPER PRODUCTS COMPRISING THE SAME |
Country Status (2)
| Country | Link |
|---|---|
| EP (1) | EP1083261A1 (en) |
| FR (1) | FR2798149B1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9511144B2 (en) | 2013-03-14 | 2016-12-06 | The Proctor & Gamble Company | Cosmetic compositions and methods providing enhanced penetration of skin care actives |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0139481A2 (en) * | 1983-09-22 | 1985-05-02 | Ajinomoto Co., Inc. | Surface modification using N-acyl lysines |
| WO1994026694A1 (en) * | 1993-05-17 | 1994-11-24 | Givaudan Lavirotte | Method for the preparation of n-acylated aminoacids |
-
1999
- 1999-09-08 FR FR9911221A patent/FR2798149B1/en not_active Expired - Fee Related
-
2000
- 2000-08-17 EP EP00402303A patent/EP1083261A1/en not_active Withdrawn
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0139481A2 (en) * | 1983-09-22 | 1985-05-02 | Ajinomoto Co., Inc. | Surface modification using N-acyl lysines |
| WO1994026694A1 (en) * | 1993-05-17 | 1994-11-24 | Givaudan Lavirotte | Method for the preparation of n-acylated aminoacids |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2798149B1 (en) | 2001-11-09 |
| EP1083261A1 (en) | 2001-03-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BE1005915A5 (en) | Composition for cleaning the skin, hair and scalp. | |
| WO1999045899A1 (en) | Synergetic composition comprising a compound with lipoaminoacid structure and a tuberous water-lily extract | |
| EP0998264A1 (en) | Composition comprising a lipoaminoacid and a tannin-rich plant extract | |
| FR2771632A1 (en) | Cosmetic compositions containing N-acyl amino acid and 1,2-diol | |
| FR2788777A1 (en) | New arginine-proline peptides, useful in cosmetics and dermatology for treating e.g. inflammation, inhibit overproduction of proinflammatory interleukins | |
| CN1177579C (en) | Skin and Hair Preparations | |
| FR2804864A1 (en) | RESIDUE EXTRACTS FROM WINE MANUFACTURING AND THEIR USE IN COSMETICS OR PHARMACOLOGY | |
| EP0593506B1 (en) | Lipoaminoacids, preparation method and applications | |
| FR2795659A1 (en) | MIXTURES OF HIGHLY CONCENTRATED FLUID ANIONIC SURFACTANTS | |
| EP0983055B1 (en) | Composition comprising an amino acid n-undecylenoyl; application in cosmetics | |
| FR2766366A1 (en) | USE OF AT LEAST ONE LIPOAMINOACID AS AN ANTAGONIST OF THE SUBSTANCE P IN A COSMETIC FORMULATION FOR SOOTHING AND / OR PROTECTING ALL SKIN TYPES AND, IN PARTICULAR, SENSITIVE SKIN | |
| FR2646603A1 (en) | CLEANING COMPOSITION | |
| FR2798149A1 (en) | USE OF LIPOAMINOACIDS IN THE MANUFACTURE OF PAPER PRODUCTS AND PAPER PRODUCTS COMPRISING THE SAME | |
| FR2765105A1 (en) | Cosmetic composition for e.g treating acne or hydrating skin and scalp | |
| EP1147765A1 (en) | New active, compositions containing it and it's use in cosmetic, dermocosmetic, dermopharmacy or pharmacy, on woven or nonwoven fabrics | |
| WO2000030604A1 (en) | Composition for preventing and treating cellulitis | |
| WO2012153015A1 (en) | Novel peptides that are modulators of the protein trf2 and compositions containing same | |
| FR2881348A1 (en) | CLEANING COSMETIC COMPOSITION IN SOLID FORM | |
| FR2798147A1 (en) | USE OF LIPOAMINOACIDS IN THE MANUFACTURE OF TEXTILE PRODUCTS AND TEXTILE PRODUCTS COMPRISING SAME | |
| FR2763842A1 (en) | COSMETIC OR DERMOPHARMACEUTICAL COMPOSITIONS CONTAINING THREONINE OR SERINE DERIVATIVES | |
| FR3069776A1 (en) | COSMETIC COMPOSITIONS FOR SKIN CARE | |
| FR2543828A1 (en) | NOVEL ANTI-ACNEIC COMPOSITION BASED ON TIOXOLONE AND AT LEAST ONE OTHER ACTIVE INGREDIENT | |
| CH494573A (en) | Skin anti-wrinkle composition contg an elastolytic | |
| CH669521A5 (en) | ||
| FR2718028A1 (en) | Skin or scalp care cosmetic or dermatological compsn. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |